Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Origins of Atlantic Salmon (<i>Salmo salar</i>) Determined Using a Hybridization Assay of Mitochondrial DNA on a Microfluidic Biochip.

Biosensors·2026
Same author

Real-Time Single-Cell Measurement and Kinetic Modeling of Daunorubicin Uptake in Multidrug-Resistant Leukemia Cells Using a Microfluidic Biochip.

Pathophysiology : the official journal of the International Society for Pathophysiology·2026
Same author

Reversal Effects of 20(R)- and 20(S)-Ginsenoside-Rg3 on Daunorubicin Uptake in Multidrug-Resistant Leukemia Cells Studied in the Single-Cell Biochip.

International journal of molecular sciences·2026
Same author

Detecting EGFR Gene Mutations on a Nanobioarray Chip.

Biomedicines·2026
Same author

Nanogold-Lateral Flow Assay for Ginseng DNA Differentiation.

Biosensors·2025
Same author

A visualization and fluorimetric detection for sulfisoxazole based on selectively weakened peroxidase activity of gold nanoclusters.

Journal of pharmaceutical and biomedical analysis·2025

Related Experiment Video

Updated: Mar 24, 2026

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells
05:58

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells

Published on: October 13, 2023

1.8K

Microfluidic Devices for Circulating Tumor Cells Isolation and Subsequent Analysis.

Avid Khamenehfar, Paul C H Li1

  • 1Department of Chemistry, Simon Fraser University, 8888 University Drive, Burnaby, BC, V5A 1S6 Canada. paulli@sfu.ca.

Current Pharmaceutical Biotechnology
|March 2, 2016
PubMed
Summary
This summary is machine-generated.

Circulating tumor cells (CTCs) are valuable for cancer diagnosis and treatment. Microfluidic devices effectively isolate these rare cells, enabling further analysis for personalized medicine.

More Related Videos

Microfluidics-based High-throughput Circulating Tumor Cell Sorting and Single-cell Sequencing Technology
09:45

Microfluidics-based High-throughput Circulating Tumor Cell Sorting and Single-cell Sequencing Technology

Published on: November 14, 2025

895
A Method of Targeted Cell Isolation via Glass Surface Functionalization
10:40

A Method of Targeted Cell Isolation via Glass Surface Functionalization

Published on: September 20, 2016

10.0K

Related Experiment Videos

Last Updated: Mar 24, 2026

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells
05:58

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells

Published on: October 13, 2023

1.8K
Microfluidics-based High-throughput Circulating Tumor Cell Sorting and Single-cell Sequencing Technology
09:45

Microfluidics-based High-throughput Circulating Tumor Cell Sorting and Single-cell Sequencing Technology

Published on: November 14, 2025

895
A Method of Targeted Cell Isolation via Glass Surface Functionalization
10:40

A Method of Targeted Cell Isolation via Glass Surface Functionalization

Published on: September 20, 2016

10.0K

Area of Science:

  • Oncology
  • Biotechnology
  • Medical Diagnostics

Background:

  • Circulating tumor cells (CTCs) hold significant potential for cancer early diagnosis, treatment management, metastasis research, and personalized medicine.
  • The rarity of CTCs in blood presents a major challenge for their isolation and subsequent analysis.
  • Microfluidic devices have emerged as promising tools for efficient CTC isolation.

Purpose of the Study:

  • To review recent advancements in microfluidic technologies for the isolation of circulating tumor cells (CTCs).
  • To discuss the capabilities of these microfluidic methods for subsequent cellular and DNA analysis of captured CTCs.
  • To highlight the progress and remaining challenges in the field of CTC analysis using microfluidics.

Main Methods:

  • Review of recent scientific literature on microfluidic devices for CTC isolation.
  • Analysis of reported capture efficiencies and purity levels achieved by various microfluidic platforms.
  • Examination of studies focusing on downstream cellular and DNA analysis of isolated CTCs.

Main Results:

  • Microfluidic devices demonstrate high efficiency and purity in capturing CTCs from blood samples.
  • While CTC enumeration is established, detailed cellular and DNA analysis post-isolation remains less explored.
  • Recent developments show increasing potential for comprehensive CTC characterization.

Conclusions:

  • Microfluidic technologies are advancing CTC isolation, offering high performance.
  • Further research is needed to fully leverage captured CTCs for in-depth molecular and cellular analysis.
  • Enhanced CTC analysis via microfluidics promises significant contributions to cancer research and clinical applications.